Table 1.
Perceived prevalence of markers of hypertension-related organ damage and cerebrovbascular diseases, including transient ischemic attack and stroke, according to physicians’ answers to survey questionnaire [questions num. 01–06]
| Question (num/text) | Answers (%) | ||
|---|---|---|---|
| Overall (N = 591) | SPs (n = 48) | GPs (n = 543) | |
| Q01. Which is the most prevalent marker of organ damage do you find in patients with hypertension in your clinical practice? | |||
| Left Ventricular Hypertrophy | 469 (80.9) | 37 (77.1) | 432 (81.2) |
| Carotid Atherosclerosis | 46 (7.9) | 6 (12.5) | 40 (7.5) |
| Microalbuminuria or Proteinuria | 34 (5.9) | 5 (10.4) | 29 (5.5) |
| Impaired eGFR or CrCl | 26 (4.5) | 0 (0.0) | 26 (4.9) |
| Impaired ABI or PWV | 5 (0.9) | 0 (0.0) | 5 (0.9) |
| Q02. Which is the prevalence of cardiac organ damage (i.e. left ventricular hypertrophy) do you find in patients with hypertension in your clinical practice? | |||
| 10–20% | 110 (18.9) | 7 (14.6) | 103 (19.3) |
| 21–40% | 278 (47.8) | 24 (50.0) | 254 (47.6) |
| 41–50% | 120 (20.6) | 10 (20.8) | 110 (20.6) |
| > 50% | 74 (12.7) | 7 (14.6) | 67 (12.5) |
| Q03. Which is the prevalence of renal organ damage (i.e. MAU, proteinuria, reduced eGFR or creatinine clearance) do you find in patients with hypertension in your clinical practice? | |||
| 10–20% | 196 (33.7) | 17 (35.4) | 179 (33.6) |
| 21–40% | 267 (46.0) | 26 (54.2) | 241 (45.2) |
| 41–50% | 88 (15.1) | 4 (8.3) | 84 (15.8) |
| > 50% | 30 (5.2) | 1 (2.1) | 29 (5.4) |
| Q04. Which is the prevalence of vascular organ damage (i.e. carotid or peripheral atherosclerosis) do you find in patients with hypertension in your clinical practice? | |||
| 10–20% | 430 (74.3) | 33 (68.8) | 397 (74.8) |
| 21–40% | 132 (22.8) | 15 (31.3) | 117 (22.0) |
| 41–50% | 11 (1.9) | 0 (0.0) | 11 (2.1) |
| > 50% | 6 (1.0) | 0 (0.0) | 6 (1.1) |
| Q05. Which is the prevalence of cerebrovascular disease (i.e. transient ischemic attack) do you find in patients with hypertension in your clinical practice? | |||
| 10–20% | 388 (67.6) | 37 (82.2) | 351 (66.4) |
| 21–40% | 143 (24.9) | 8 (17.8) | 135 (25.5) |
| 41–50% | 35 (6.1) | 0 (0.0) | 35 (6.6) |
| > 50% | 8 (1.4) | 0 (0.0) | 8 (1.5) |
| Q06. Which is the prevalence of cerebrovascular disease (i.e. stroke) do you find in patients with hypertension in your clinical practice? | |||
| 10–20% | 432 (75.0) | 42 (93.3) | 390 (73.4) |
| 21–40% | 116 (20.1) | 3 (6.7) | 113 (21.3) |
| 41–50% | 24 (4.2) | 0 (0.0) | 24 (4.5) |
| > 50% | 4 (0.7) | 0 (0.0) | 4 (0.8) |
SPs specialized physicians, GPs general practitioners, MAU microalbuminuria, eGFR estimated glomerular filtration rate